L
Lycia Therapeutics
1 follower
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Org chart
Aetna Wun Trombley
President & CEO
Collapse
Steve Staben
Chief Scientific Officer
Winsome Chung
VP, Finance
Larry Rozsnyai
Vice President, Intellectual Property
Darrin Lindhout
Head of Biologics
Board & advisors
William J. Rieflin
Chair
Tim Anderson
Director
Laurent Fischer
Director
Clare Ozawa
Director
Tom Woiwode
Director
Carolyn Bertozzi
Chair
Monther Abu-Remaileh
Scientific Advisory Board
Mark M. Davis
Advisor
Randy Schekman
Advisor
Alanna Schepartz
Advisor
Daniel D. Von Hoff
Advisor